Bio Pharma Dive
MAY 13, 2022
Tirzepatide, now branded as Mounjaro, helped improve blood sugar control in testing and has been shown to have powerful weight loss effects as well, making it one of the most closely watched drugs in Lilly's pipeline.
World of DTC Marketing
MAY 9, 2022
Short on Time? Adalytics r eported that for nine months, billions of ad auctions for space on Gannett’s USA Today website resulted in brands unknowingly getting stuck with their ads running on other Gannett sites — often remote community sites. Ads from who-knows-how-many companies ran in the wrong places for nine months. Not a single brand noticed this, and not a single media buyer noticed the fraud.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
MAY 11, 2022
Antimicrobial resistance is a growing problem and one that is already claiming over a million lives per year. The situation is urgent but finding a sustainable solution is a difficult prospect, finds Ben Hargreaves. Alexander Fleming discovered the world’s first antibiotic, penicillin, in 1928. However, the difficulty in developing a method to adequately produce sufficient levels of the product meant that the age of the antibiotic did not truly begin until the 1940s.
Deltaclinical
MAY 13, 2022
On May 12, we celebrate Nurses Day! Sometimes it seems that we have forgotten the past 2 years. Because even after a pademic, nurses are there for us day and night. And they do this with a clear goal in mind: making other people better and taking care of those in need. It is therefore more than deserved to put all nurses in the spotlight today! THANK YOU to everyone who provides warm and professional care every day!
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Bio Pharma Dive
MAY 11, 2022
Regulators in New Zealand have allowed human testing to proceed, another milestone for the gene editing technology. Verve plans to soon ask for approval to begin testing in the U.S. and U.K., too.
Pharma Mirror
MAY 13, 2022
Rockville, Emmes – a global, full-service Contract Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, announces that it will introduce to market its third generation version of Advantage eClinical at Society for Clinical Trials (SCT) in San Diego, May 15th – 18th. The cloud platform of Advantage eClinical will be available as a standalone software product after undergoing more than two years of development.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Deltaclinical
MAY 13, 2022
On May 12, we celebrate Nurses Day! Sometimes it seems that we have forgotten the past 2 years. Because even after a pademic, nurses are there for us day and night. And they do this with a clear goal in mind: making other people better and taking care of those in need. It is therefore more than deserved to put all nurses in the spotlight today! THANK YOU to everyone who provides warm and professional care every day!
Bio Pharma Dive
MAY 10, 2022
The rest of Biohaven's pipeline, which includes drugs for ALS and obsessive compulsive disorder, will be spun out into a new company led by the biotech's current CEO and retaining its name.
Pharma Mirror
MAY 7, 2022
Singapore, Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced it will create a new manufacturing and distribution Hub in Singapore, by integrating its existing distribution facility with new manufacturing operations.
pharmaphorum
MAY 9, 2022
Mental health issues among teens and young adults have risen dramatically over the past decade. Jessica Lake, chief science officer at Limbix, tells us about SparkRx, a digital therapeutics app aimed to help treat adolescent depression. . SparkRx is designed to decrease depression in individuals aged 13 to 22 by providing a multi-week programme based on cognitive behavioural therapy (CBT) and behavioural activation protocols.
Deltaclinical
MAY 13, 2022
On May 12, we celebrate Nurses Day! Sometimes it seems that we have forgotten the past 2 years. Because even after a pademic, nurses are there for us day and night. And they do this with a clear goal in mind: making other people better and taking care of those in need. It is therefore more than deserved to put all nurses in the spotlight today! THANK YOU to everyone who provides warm and professional care every day!
Bio Pharma Dive
MAY 9, 2022
The company's board is investigating the allegation, which Siegall, who has led Seattle's largest biotech for 24 years, denied. Chief Medical Officer and former Merck executive Roger Dansey was named interim CEO.
Pharma Times
MAY 10, 2022
NICE recommendation for Forxiga could entitle 53,000 adults to the new kidney disease therapy
pharmaphorum
MAY 13, 2022
The unprecedented rate of digital acceleration seen in the first two years of COVID-19 has set in train an age of digital transformation. In my last article, I outlined the inflection point facing the pharmaceutical industry in digital health and the digital transformation of its clinical and commercial operations. This time I’m going to focus on one company and its view on pharma’s digital commercial strategy.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Deltaclinical
MAY 13, 2022
On May 12, we celebrate Nurses Day! Sometimes it seems that we have forgotten the past 2 years. Because even after a pademic, nurses are there for us day and night. And they do this with a clear goal in mind: making other people better and taking care of those in need. It is therefore more than deserved to put all nurses in the spotlight today! THANK YOU to everyone who provides warm and professional care every day!
Bio Pharma Dive
MAY 9, 2022
The companies' hepatitis B program never reached clinical testing, while J&J said it would no longer develop an HPV vaccine because of the "widespread uptake" of effective shots from other companies.
Pharma Times
MAY 12, 2022
High street service has been launched to support those experiencing symptoms potentially connected to the menopause
pharmaphorum
MAY 10, 2022
Researchers in the US have developed a wearable monitor that could be used to monitor metabolic diseases through gases released from a person’s skin. It’s a spin on the use of monitors that detect chemicals in sweat using electrical signals and has the key advantage that it does not need substantial amounts of sweat to get a reading, according to the team from Ohio State University.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
MAY 13, 2022
The disease of malaria is triggered by single-celled parasites that accumulate in large groups in the salivary glands of mosquitoes before transmission to human beings. The limited space there prevents them from actually moving, unless this restriction is lifted by means of appropriate experimental preparation. In just such experiments, researchers at Heidelberg University have set […].
Bio Pharma Dive
MAY 11, 2022
Jorge Gomez, who officially took the CFO reins Monday, lasted one day on the job. His departure comes as Gomez's previous company, Dentsply Sirona, looks into financial allegations against current and former executives.
Pharma Times
MAY 11, 2022
Nirsevimab is the first investigational immunisation designed to protect all infants across the RSV season with a single dose
pharmaphorum
MAY 9, 2022
A study has shown that a mobile game can be used to gather symptom data from children undergoing treatment for cancer, and potentially might also be used to provide personalised management of their care. That is the conclusion of a small US study looking at the role of Color Me Healthy, a gaming app developed through a collaboration between children, game designers and clinical staff.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
XTalks
MAY 10, 2022
Researchers at the University of Manchester have developed a new blood test that can help diagnose ovarian cancer faster and more accurately in women, particularly those under the age of 50, using a newer ovarian cancer biomarker. The blood test can be administered by general practitioners/physicians. The test includes the use of the emerging ovarian cancer biomarker, human epididymis protein 4 (HE4).
Bio Pharma Dive
MAY 10, 2022
The biotech's Series B round, which kicked off early this year, should be able to fuel its work on "molecular machines" until at least 2024, according to CEO Asit Parikh.
Pharma Times
MAY 13, 2022
Data shows that 1.
pharmaphorum
MAY 11, 2022
Danish drugmaker Novo Nordisk has traditionally generated its pipeline mainly from internal R&D, but a new alliance with venture capital firm Flagship Pioneering signals another departure from that strategy. The partnership with Flagship will bring Novo Nordisk into closer contact with the VC’s portfolio of 41 biotech companies, with the aim of creating a portfolio of “transformational” medicines for cardiometabolic and rare diseases.
Scienmag
MAY 13, 2022
Redness, swelling, pain – these are signs of inflammation. It serves to protect the body from pathogens or foreign substances. Researchers from the Universities of Bonn and Cologne were able to show that inflammatory reactions of an important sensor protein proceed in a specific spatial direction. This finding has the potential to conceivably stop inflammation […].
Bio Pharma Dive
MAY 12, 2022
Deucravacitnib, forecast by Bristol Myers to hit $4 billion in peak sales, is under FDA review with an approval decision due by September. The agency's view of its safety will be key to its future.
Pharma Times
MAY 9, 2022
Vital patent for Evotenix is anticipated to enable a new generation of DNA synthesis platforms
pharmaphorum
MAY 13, 2022
When it comes to enthusiasm about digital innovation, pharma seems to be more adept at talking the talk than walking the walk, as it were. That’s according to recent survey data from digital agency Graphite. Working with Reuters Events, the agency surveyed 450 healthcare executives, 85% of whom worked in pharma. A full 92% of the survey respondents agreed with the statement “Pharma-sponsored digital products can add value to the healthcare provider and patient by supporting the overall customer
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Expert insights. Personalized for you.
354 
Let's personalize your content